fda
10 records
FDA Drug Recall: Bimatoprost powder, Bulk Ingredient, a) 5g (NDC 38779-3066-03), b) 1g (NDC 38779
2025-04-30
Class II — CGMP Deviations
View Source
FDA Drug Recall: Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline p
2024-07-10
Class II — CGMP Deviations and Presence of Particulate Matter: Glass
View Source
FDA Drug Recall: Estriol, USP (Micronized) 1 g, 5 g, 25 g, 100 g, 2000 g, 1 kg, containers, Packe
2019-12-25
Class II — Failed Impurities/Degradation Specifications
View Source
FDA Drug Recall: Aminocaproic Acid, USP (6-Aminohexanoic Acid) active pharmaceutical ingredient,
2017-09-27
Class II — CGMP Deviations: Product manufactured for Industrial Use but was labeled and distributed for Pharmacy Compounding Use.
View Source
FDA Drug Recall: ESTRADIOL, USP (Hemihydrate)(Micronized), in a) 100 mg (NDC 38779-0869-07), b) 1
2017-04-19
Class II — cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection
View Source
FDA Drug Recall: ESTRIOL, USP (Micronized) Bulk, in a) 5 grams (NDC 38779-0732-03), b) 25 grams (
2017-04-19
Class II — cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection
View Source
FDA Drug Recall: ESTRADIOL, USP Bulk (Hemihydrate), in a) 25 g (NDC 38779-2261-04) and b) 100 g
2017-04-19
Class II — cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection
View Source
FDA Drug Recall: ESTRONE, USP Bulk, in a) 100 mgs (NDC 38779-0891-05), b) 1 gram (NDC 38779-0891-
2017-04-19
Class II — cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection
View Source
FDA Drug Recall: CITRULLINE (L) in 25 g, 100 g, 500 g and 1 kg plastic bottles, White crystals or
2016-02-24
Class I — Labeling: Label Mix-Up: FDA tested samples of API from Medisca, labeled as to contain L-Citrulline, and results revealed no L-Citrulline was present. Levels of N-acetyl-leucine were found in...
View Source
FDA Drug Recall: Human Chorionic Gonadotropin, EP (HCG) in 5 mu. 2 mu, and 1 mu packages, For use
2014-05-07
Class I — Labeling: Label Error on Declared Strength; Firm states that erroneous potency information was found on the label.
View Source
lobbying
2 records
Lobbying Client: MEDISCA INC.
Lobbied by VENABLE LLP — Pharmaceutical ingredients and tech procurement, repackaging, and distribution company
View Source
Lobbying Client: MEDISCA INC.
Lobbied by VENABLE LLP — Pharmaceutical ingredients and tech procurement, repackaging, and distribution company
View Source
ny_corps
1 records
NY Corp: MEDISCA INC.
1992-06-24
DOMESTIC BUSINESS CORPORATION | County: Clinton | Jurisdiction: New York
View Source
ny_spills
3 records
NY Spill: MEDISCA INC — unknown hazardous material
2007-09-11
PLATTSBURGH, Clinton County | 2.00 Gallons of unknown hazardous material
NY Spill: MEDISCA INC — unknown hazardous material
2007-09-11
PLATTSBURGH, Clinton County | 2.00 Gallons of unknown hazardous material
NY Spill: MEDISCA INC — unknown hazardous material
2007-09-11
PLATTSBURGH, Clinton County | 2.00 Gallons of unknown hazardous material
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.